Lettmann Jason
ALX Oncology Holdings Inc. · CHIEF EXECUTIVE OFFICER
Lettmann Jason is listed in filings as CHIEF EXECUTIVE OFFICER at ALX Oncology Holdings Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including sale activity and purchase activity. Recent filings connect the profile to ALX Oncology Holdings Inc. (ALXO). The current snapshot covers public activity from Aug 16, 2024 to Mar 23, 2026. Reported amounts are shown as $26.7K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $77k71.2k shares | BuySep 17, 2025 | $1.08 | $2.10 | |
| $22k21.1k shares | BuySep 16, 2025 | $1.07 | $2.10 | |
| $1.5k2.4k shares | SellAug 15, 2025 | $0.6404 | $2.10 | |
| $2.5k2.2k shares | SellFeb 19, 2025 | $1.15 | $2.10 |